Latest Plavix NewsRSS

03:36 EDT 23rd September 2017 | BioPortfolio

Global Cardiovascular Partnering 20102017: Deal trends, players and financials [Report Updated: 01092017] Prices from USD $2995

Global Cardiovascular Partnering 2010 to 2017 provides the full collection of Cardiovascular disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Cardiovascular partnering dealsFinancial deal terms for headline, upfront and royalty by stage of developmentCardiovascular partnering agreement structureCardiovascular partnering contract documentsTop...

Cardiovascular Drug Delivery technologies,markets and companies [Report Updated: 08092017] Prices from USD $2800

SummaryDrug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to all organs of the body. Drugs can be introduced into the vascular system for systemic effects or targeted to an organ via the regional blood supply. In addition to the usual formulations of drugs such as contr...

Drug discovery alliance 'plugs a growing gap' in pharma's drug safety capabilities, says co-founder

ApconiX and PhysioStim have joined forces to create a European center of excellence for preclinical cardiovascular safety evaluation.

Study explores predictors of clinical restenosis in newer, bioresorbable scaffolds

New research published in the Journal of the American College

diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Dec. 5, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans to present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disord...

Review suggests whole grains might not be as heart-healthy as we think

Primary Asset: Body:  We all know whole grains are our best dietary bet for staying healthy—right?One University of Warwick physician in the U.K. has suggested eating a diet rich in whole grains actually hasn’t been proven to be beneficial to heart health, Reuters reports. Karen Rees, PhD, recently published a research review in the Cochrane Library concluding any past experiments te...

Weekly exenatide injections have no impact on cardiovascular outcome in diabetics

After testing a once-weekly injectable form of glucose-lowering drug exenatide o

AHA, ACC launch 'capstone' accreditation program for cardiovascular care

Regional Hospital of Scranton (Pennsylvania) is the first hospital in

Patients with schizophrenia face shorter lives, greater cardiovascular risk

Despite an overall decline in mortality of indiv


LONDON, Sept. 19, 2017 /PRNewswire/ -- KEY FINDINGSGlobally, cardiovascular diseases (CVD) are the primary cause of deaths. Hence, the treatment of these diseases is of utmost priority at present.The global cardiovascular surgical devices market is expected to rise at a CAGR of 8.26% over the forecast period of 2017-2025, generating $102252 million by 2025. The rising incidences of cardiac disorde...

CardioVascular Coalition Urges Adoption of National Strategy to Address Unnecessary Amputations During Peripheral Artery Disease (PAD) Awareness Month

Washington, DC, September 19, 2017 --( The CardioVascular Coalition (CVC), a leading group of community-based cardiovascular and endovascular care providers, physicians and manufacturers created to advance community-based solutions designed to improve awareness, prevention and intervention of vascular disease, is urging healthcare leaders, policymakers, patient advocates and other stakeh...

AstraZeneca HealthCare Foundation Awards Nearly $1 Million to 10 Innovative Heart Health Programs & Announces Open Call for Applications

The AstraZeneca HealthCare Foundation’s Connections for Cardiovascular HealthSM (CCH) program is awarding nearly $1 million in grants to 10 organizations working to help improve cardiovascular health in their communities and is also announcing the availability of additional grants in 2018. The organizations receiving grants this year will work t...

For U.S. Cardiologists, Age and Income Continue to Rise

New Survey of 2,300+ Physicians Reveals Significant Health Care Industry Trends MedAxiom, the nation’s leading cardiovascular health care performance community and top CV-specific consulting firm, has released its fifth annual Cardiovascular Provider Compensation & Production Survey—a highly sought-after resource for health care decision-makers...

Former CDC Chief Launches $225 Million Global Health Initiative

Mike Bloomberg, Mark Zuckerberg, and Bill Gates team up to combat the global burdens of heart disease and infectious epidemics. SOURCE: Bloomberg DESCRIPTION:By Lena H. Sun Tom Frieden, former director of the Centers for Disease Control and Prevention, is starting a new initiative to tackle some of global health’s thorniest issues: cardiovascular disease and epidemics. Frieden, a former New Yo...

Cardax Welcomes Cardiovascular Research Breakthrough

HONOLULU, Sept. 19, 2017 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) welcomes the findings of a clinical study recently published in the New England Journal of Medicine that validate the crucial role inflammation plays in cardiovascular health. The 10,000 patient, double-blind, placebo-controlled study ("CANTOS") sponsored by Novartis demonstrated, for the first time in history, that an anti‑infla...

Heart disease, tobacco leading causes of global deaths in 2016

Body:  Chronic diseases, including heart disease and diabetes, caused 72 percent of deaths worldwide in 2016, according to the recently released Global Burden of Disease study.The study, published in The Lancet last week, found that cardiovascular disease (CVD), tobacco and violence were the leading causes of death across the globe last year, with heart disease as the leading cause of prematu...

Cerebral embolic protection device cuts risk of TAVR procedures

Adding a cerebral embolic protection (CEP) device to standard transcatheter aortic valve replacement (TAVR) was associated with a threefold

ASNC and ASE Team Up to Expand the ImageGuide Registry

ASNC and ASE presidents sign a proclamation announcing the development of the new ASE Echocardiography module in the ImageGuide Registry. Kansas City, Mo. (PRWEB) September 18, 2017 The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced at ASNC’s 22nd Annual Scientific Sessions a partnership to develop an ASE Echocardiography Modul...

Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2017

LONDON, Sept. 18, 2017 /PRNewswire/ -- Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2017, provides an overview of the Deep Vein Thrombosis (DVT) (Cardiovascular) pipeline landscape.Download the full report:

Cardiovascular Systems Announces Anticipated Revenue Impact from Hurricanes Harvey and Irma

Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) today said that the impact of Hurricanes Harvey and Irma on procedure volumes in the greater Houston area and throughout Florida will reduce fiscal 2018 first-quarter revenues. “Our thoughts go out to our employees in Florida and Texas and others affected by Hurricanes Harvey and Irma,” said Sco...

Ncardia Established Following Pluriomics Axiogenesis Merger

Builds foundation to become the trusted leader in hiPSC based drug discovery solutions Ncardia ( has been established following the merger of Pluriomics and Axiogenesis. The privately held company with operations in Europe and the US, produces and commercializes high-quality, fully functional hiPSC derived

Cardiovascular risk in urban food deserts linked to income, not food access

Americans who live in poorer, urban areas and those who have less income are least likely to consume healthy food, regardless of their access to it, according to a study published in the American Heart Association’s journal Circulation.

CV death risk decreases with evolocumab in atherosclerotic disease

The risks for cardiovascular death, myocardial infarction and stroke are reduced in adults with atherosclerotic disease with or without diabetes treated with the PCSK9 inhibitor evolocumab, according to findings from the FOURIER trial presented at the European Association for the Study of Diabetes Annual Meeting and published simultaneously in The Lancet Diabetes & Endocrinology.Marc S. Sabatine, ...

The Heart Course: Cardiovascular and Neurovascular Care for the Frontline Provider

12th Annual Conference - The Heart Course: Cardiovascular and Neurovascular Care for the Frontline Provider - November 6-9, 2017 in Las Vegas, NV JOHNSBURG, IL (PRWEB) September 15, 2017 Every minute, an American dies from a cardiovascular emergency. Seconds can mean the difference between life and death. The Heart Course: Cardiovascular and Neurovascular Care for the Frontline Provider, a 4-day ...

A French Biotech Planning to Take Vascular Medical Devices to the Next Level

This week we are just outside Paris visiting Sensome, a biotech developing exciting technology to turn vascular medical devices into connected healthcare devices. Mission: Sensome’s big aim is to produce implantable devices for neurovascular, peripheral vascular and cardiovascular conditions. Their sensor ... This awesome article A French Biotech Planning to Take Vascular Medical Devices to...

Quick Search

review and buy Plavix market research data and corporate reports here